Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Manuel Battegay and Hans Hirsch.
Connection Strength

1.520
  1. Corrigendum to: Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Emergence Amidst Community-Acquired Respiratory Viruses. J Infect Dis. 2021 02 24; 223(4):734-735.
    View in: PubMed
    Score: 0.233
  2. Epidemiology and precision of SARS-CoV-2 detection following lockdown and relaxation measures. J Med Virol. 2021 04; 93(4):2374-2384.
    View in: PubMed
    Score: 0.230
  3. Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Emergence Amidst Community-Acquired Respiratory Viruses. J Infect Dis. 2020 09 14; 222(8):1270-1279.
    View in: PubMed
    Score: 0.226
  4. 2019-novel Coronavirus (2019-nCoV): estimating the case fatality rate - a word of caution. Swiss Med Wkly. 2020 01 27; 150:w20203.
    View in: PubMed
    Score: 0.216
  5. Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab - a single centre cohort study. Swiss Med Wkly. 2021 08 02; 151:w20550.
    View in: PubMed
    Score: 0.060
  6. Global Genomic Analysis of SARS-CoV-2 RNA Dependent RNA Polymerase Evolution and Antiviral Drug Resistance. Microorganisms. 2021 May 19; 9(5).
    View in: PubMed
    Score: 0.059
  7. SARS-CoV-2 outbreak in a tri-national urban area is dominated by a B.1 lineage variant linked to a mass gathering event. PLoS Pathog. 2021 03; 17(3):e1009374.
    View in: PubMed
    Score: 0.058
  8. Systematic screening on admission for SARS-CoV-2 to detect asymptomatic infections. Antimicrob Resist Infect Control. 2021 02 27; 10(1):44.
    View in: PubMed
    Score: 0.058
  9. Community-acquired and hospital-acquired respiratory tract infection and bloodstream infection in patients hospitalized with COVID-19 pneumonia. J Intensive Care. 2021 Jan 18; 9(1):10.
    View in: PubMed
    Score: 0.058
  10. COVID-19 Triage and Test Center: Safety, Feasibility, and Outcomes of Low-Threshold Testing. J Clin Med. 2020 Oct 07; 9(10).
    View in: PubMed
    Score: 0.057
  11. Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect. J Antimicrob Chemother. 2020 10 01; 75(10):3084-3086.
    View in: PubMed
    Score: 0.057
  12. Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations. Antimicrob Agents Chemother. 2020 08 20; 64(9).
    View in: PubMed
    Score: 0.056
  13. Reproductive number of the COVID-19 epidemic in Switzerland with a focus on the Cantons of Basel-Stadt and Basel-Landschaft. Swiss Med Wkly. 2020 05 04; 150:w20271.
    View in: PubMed
    Score: 0.055
  14. The rate of mother-to-child transmission of antiretroviral drug-resistant HIV strains is low in the Swiss Mother and Child HIV Cohort Study. Swiss Med Wkly. 2019 Mar 25; 149:w20059.
    View in: PubMed
    Score: 0.051
  15. Specificity of two HIV screening tests detecting simultaneously HIV-1 p24 antigen and antibodies to HIV-1 and -2. J Virol Methods. 2017 11; 249:143-146.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.